株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のリキッドバイオプシー市場の予測:2018年~2028年

Global Liquid Biopsy Market Forecast 2018-2028: Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services

発行 Visiongain Ltd 商品コード 452416
出版日 ページ情報 英文 156 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=147.20円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
世界のリキッドバイオプシー市場の予測:2018年~2028年 Global Liquid Biopsy Market Forecast 2018-2028: Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services
出版日: 2018年04月24日 ページ情報: 英文 156 Pages
概要

当レポートでは、世界のリキッドバイオプシー市場について調査分析し、セグメント別の収益予測、地域・国別の収益予測、市場の促進要因・抑制要因、主要企業の見通しについて、体系的な情報を提供しています。

Figure 8.24 Republic of South Africa Liquid Biopsy Market, Revenue ($m),2017-2028

第1章 レポート概要

第2章 リキッドバイオプシー市場の概要

  • 経緯
  • メリット
  • 市場動向
  • 市場力学
  • 収益予測

第3章 世界のリキッドバイオプシー市場:製品タイプ別

  • 収益予測
  • 装置
  • キット・試薬
  • サービス
  • 市場シェア分析

第4章 世界のリキッドバイオプシー市場:サンプルタイプ別

  • 収益予測
  • 血液サンプル
  • 尿サンプル
  • その他
  • 市場シェア分析

第5章 世界のリキッドバイオプシー市場:バイオマーカータイプ別

  • 収益予測
  • CTC
  • ctDNA
  • エキソソーム
  • その他
  • 市場シェア分析

第6章 世界のリキッドバイオプシー市場:がんタイプ別

  • 収益予測
  • 乳がん
  • 大腸がん
  • 肝臓がん
  • 肺がん
  • 前立腺がん
  • その他
  • 市場シェア分析

第7章 世界のリキッドバイオプシー市場:エンドユーザー別

  • 収益予測
  • 病院
  • 臨床検査室
  • 学術機関
  • がん研究センター
  • 市場シェア分析

第8章 世界のリキッドバイオプシー市場:主要国別

  • 収益予測
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第9章 リキッドバイオプシー市場における主要企業

  • Menarini Silicon Biosystems, Inc.
  • MDxHealth SA
  • Biocept, Inc.
  • Trovagene, Inc.
  • Sysmex Inostics GmbH (Sysmex Corporationの子会社)
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Qiagen N.V.

第10章 リキッドバイオプシー市場の定性分析

  • PESTEL分析

第11章 結論

目次
Product Code: PHA0304

Liquid Biopsies - our new study reveals trends, R&D progress, and predicted revenues

Where is the liquid biopsy market heading? If you are involved in this sector you must read this brand-new report. Visiongain's report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead

Our 156-page report provides 144 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing liquid biopsy market. See how to exploit the opportunities.

Forecasts to 2028 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, you find revenue forecasts for 5 different segmentations of the market, including forecasts for 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end users:

  • Liquid biopsy Market Forecasts to 2028, By Product Type
  • Instruments
  • Kits & Reagents
  • Services
  • Liquid biopsy Market Forecasts to 2028, By Sample Type
  • Blood
  • Urine
  • Other
  • Liquid biopsy Technologies Market Forecasts to 2028, By Biomarker Type
  • CTC
  • ctDNA
  • Exosomes
  • Liquid biopsy Technologies Market Forecasts to 2028, By Application
  • Breast Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Liquid biopsy Technologies Market Forecasts to 2028, By End User
  • Hospitals
  • Academic Institutes
  • Diagnostic Laboratories
  • Cancer Research Centres

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts 5 leading regional markets and 19 leading national markets:

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • APAC
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia & New Zealand
  • Rest of APAC
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

image1

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2028. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth

Overall world revenue for liquid biopsy will surpass $600bn in 2018, our work calculates. We predict strong revenue growth through to 2028.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Liquid biopsy Technologies Market report helps you

In summary, our 156-page report provides you with the following knowledge:

  • Revenue forecasts to 2028 for the world liquid biopsy market and 5 different segmentations, with 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end-user types - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2028 for the leading 5 regional and 19 national markets - North America (US, Canada), Latin America (Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), APAC (Japan, China, India, South Korea, Singapore, Australia & New Zealand and Rest of APAC), LAMEA (GCC, South Africa and Rest of MEA)
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the "enter sector" market and leading companies. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Liquid Biopsy Market Overview
  • 1.2 Liquid Biopsy Market Definition & Scope
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 How This Report Delivers
  • 1.7 Who is This Report For?
  • 1.8 Methodology
    • 1.8.1 Primary Research
    • 1.8.2 Secondary Research
    • 1.8.3 Market Evaluation & Forecasting Methodology
  • 1.9 Frequently Asked Questions (FAQ)
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Liquid Biopsy Market Overview

  • 2.1 History of Liquid Biopsies
  • 2.2 Advantages of Liquid Biopsies
  • 2.3 Trends in Liquid Biopsy Market
    • 2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits
    • 2.3.2 Emergence of Oncogenic Mutations Detection Platforms
    • 2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures
  • 2.4 Market Dynamics
    • 2.4.1 Drivers
      • 2.4.1.1 Rise in global incidence of cancer
      • 2.4.1.2 Increasing Rate of Aging Population
      • 2.4.1.3 Rise in demand for safe and minimally invasive procedures
      • 2.4.1.4 Advantages of liquid biopsy
    • 2.4.2 Restraints
      • 2.4.2.1 Disparity in reimbursements
      • 2.4.2.2 Strict regulatory environment
    • 2.4.3 Opportunities:
      • 2.4.3.1 Increasing involvement of global market players through collaborations/agreements
      • 2.4.3.2 Progress in the development of liquid biopsy tests
  • 2.5 Global Liquid Biopsy Market: Revenue Forecast, 2017-2028

3. Global Liquid Biopsy Market, by Product Type 2018-2028

  • 3.1 Global Liquid Biopsy Market, By Product Type, Revenue Forecast, 2018-2028
  • 3.2 Instruments Segment
    • 3.2.1 Global Liquid Biopsy Market, Instruments Segment Revenue Forecast, 2018-2028
  • 3.3 Kits & Reagents Segment
    • 3.3.1 Global Liquid Biopsy Market, Kits & Reagents Segment Revenue Forecast, 2018-2028
  • 3.4 Services Segment
    • 3.4.1 Global Liquid Biopsy Market, Services Segment Revenue Forecast, 2018-2028
  • 3.5 Market Share Analysis, by Product Type

4. Global Liquid Biopsy Market, by Sample Type 2018-2028

  • 4.1 Global Liquid Biopsy Market, By Sample Type, Revenue Forecast, 2018-2028
  • 4.2 Global Liquid Biopsy Market, Blood Sample Segment Revenue Forecast, 2018-2028
  • 4.3 Global Liquid Biopsy Market, Urine Sample Segment Revenue Forecast, 2018-2028
  • 4.4 Global Liquid Biopsy Market, Other Samples Revenue Forecast, 2018-2028
  • 4.5 Market Share Analysis, by Sample Type

5. Global Liquid Biopsy Market, by Biomarker Type 2018-2028

  • 5.1 Global Liquid Biopsy Market, By Biomarker Type, Revenue Forecast, 2018-2028
  • 5.2 Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue Forecast, 2018-2028
  • 5.3 Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue Forecast, 2018-2028
  • 5.4 Global Liquid Biopsy Market, Exosomes Segment Revenue Forecast, 2018-2028
  • 5.5 Global Liquid Biopsy Market, Other Biomarkers Segment Revenue Forecast, 2018-2028
  • 5.6 Market Share Analysis, by Biomarker Type

6. Global Liquid Biopsy Market, by Cancer Type 2018-2028

  • 6.1 Global Liquid Biopsy Market, By Cancer Type, Revenue Forecast, 2018-2028
  • 6.2 Global Liquid Biopsy Market, Breast Cancer Segment Revenue Forecast, 2018-2028
  • 6.3 Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue Forecast, 2018-2028
  • 6.4 Global Liquid Biopsy Market, Liver Cancer Segment Revenue Forecast, 2018-2028
  • 6.5 Global Liquid Biopsy Market, Lung Cancer Segment Revenue Forecast, 2018-2028
  • 6.6 Global Liquid Biopsy Market, Prostate Cancer Segment Revenue Forecast, 2018-2028
  • 6.7 Global Liquid Biopsy Market, Other Cancers Segment Revenue Forecast, 2018-2028
  • 6.8 Market Share Analysis, by Cancer Type

7. Global Liquid Biopsy Market, by End User 2018-2028

  • 7.1 Global Liquid Biopsy Market, By End User, Revenue Forecast, 2018-2028
  • 7.2 Global Liquid Biopsy Market, Hospitals Segment Revenue Forecast, 2018-2028
  • 7.3 Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue Forecast, 2018-2028
  • 7.4 Global Liquid Biopsy Market, Academic Institutions Segment Revenue Forecast, 2018-2028
  • 7.5 Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue Forecast, 2018-2028
  • 7.6 Market Share Analysis, by End User

8. Global Liquid Biopsy Market, by Leading Nationals 2018-2028

  • 8.1 Global Liquid Biopsy Market, By Leading Nationals, Revenue Forecast, 2018-2028
  • 8.2 North America
    • 8.2.1 North America Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.2.2 North America Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
    • 8.2.3 US Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.2.4 Canada Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.2.5 Mexico Liquid Biopsy Market, Revenue Forecast, 2018-2028
  • 8.3 Europe
    • 8.3.1 Europe Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.2 Europe Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
    • 8.3.3 Germany Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.4 France Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.5 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.6 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.7 Italy Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.8 Spain Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.3.9 Russia Liquid Biopsy Market, Revenue Forecast, 2018-2028
  • 8.4 Asia-Pacific
    • 8.4.1 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.4.2 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
    • 8.4.3 Japan Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.4.4 China Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.4.5 Australia Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.4.6 South Korea Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.4.7 India Liquid Biopsy Market, Revenue Forecast, 2018-2028
  • 8.5 LAMEA
    • 8.5.1 LAMEA Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.5.2 LAMEA Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
    • 8.5.3 Brazil Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.5.4 Turkey Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.5.5 Venezuela Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.5.6 Saudi Arabia Liquid Biopsy Market, Revenue Forecast, 2018-2028
    • 8.5.7 Republic of South Africa Liquid Biopsy Market, Revenue Forecast, 2018-2028

9. Leading Companies in Liquid Biopsy Market

  • 9.1 Menarini Silicon Biosystems, Inc.
    • 9.1.1 Overview
    • 9.1.2 Technology
    • 9.1.3 Products
    • 9.1.4 Recent Strategic Developments
  • 9.2 MDxHealth SA
    • 9.2.1 Overview
    • 9.2.2 Financials
    • 9.2.3 Products
    • 9.2.4 Recent Strategic Developments
  • 9.3 Biocept, Inc.
    • 9.3.1 Overview
    • 9.3.2 Financials
    • 9.3.3 Products
    • 9.3.4 Recent Strategic Developments
  • 9.4 Trovagene, Inc.
    • 9.4.1 Overview
    • 9.4.2 Technology
    • 9.4.3 Financials
    • 9.4.4 Products
    • 9.4.5 Recent Strategic Developments
  • 9.5 Sysmex Inostics GmbH (A Subsidiary of Sysmex Corporation)
    • 9.5.1 Overview
    • 9.5.2 Technology
    • 9.5.3 Products
    • 9.5.4 Financials
    • 9.5.5 Recent Developments
  • 9.6 F. Hoffmann-La Roche AG
    • 9.6.1 Overview
    • 9.6.2 Financials
    • 9.6.3 Products
    • 9.6.4 Recent Strategic Developments
  • 9.7 Bio-Rad Laboratories, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financials
    • 9.7.3 Products
    • 9.7.4 Recent Strategic Developments
  • 9.8 Guardant Health, Inc.
    • 9.8.1 Overview
    • 9.8.2 Products
    • 9.8.3 Recent Strategic Developments
  • 9.9 Illumina, Inc.
    • 9.9.1 Overview
    • 9.9.2 Financials
    • 9.9.3 Recent Strategic Developments
  • 9.10 Myriad Genetics, Inc.
    • 9.10.1 Overview
    • 9.10.2 Financials
    • 9.10.3 Products
    • 9.10.4 Recent Strategic Developments
  • 9.11 Qiagen N.V.
    • 9.11.1 Overview
    • 9.11.2 Financials
    • 9.11.3 Products
    • 9.11.4 Recent Strategic Developments

10. Qualitative Analysis of the Liquid Biopsy Market

  • 10.1 PESTEL Analysis of the Liquid Biopsy Market
    • 10.1.1 Political
      • 10.1.1.1 Regulatory Bodies:
      • 10.1.1.2 Insurance / Reimbursement:
    • 10.1.2 Economic
    • 10.1.3 Social
    • 10.1.4 Environmental Factors
    • 10.1.5 Technological
      • 10.1.5.1 Decline in use of Old Technologies and Advent of New Technologies
      • 10.1.5.2 Early Stage Diagnosis of Cancer with Liquid Biopsies
      • 10.1.5.3 Improved Liquid Biopsy Techniques
      • 10.1.5.4 Comparison with Tissue Sampling
      • 10.1.5.5 Cost Reductions and Time Saving with Liquid Biopsies
    • 10.1.6 Legal
      • 10.1.6.1 Regulatory Science Challenge
      • 10.1.6.2 FDA
      • 10.1.6.3 Lawsuits and Litigations

11. Conclusion

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B

Table of Tables

  • Table 1.1 Global Liquid Biopsy Market Forecast Segmented by Product Type Revenue ($m), AGR (%) and CAGR (%), 2017-2028
  • Table 2.1: Global Liquid Biopsy Market, Revenue ($m) and AGR (%) 2017-2028
  • Table 3.1: Global Liquid Biopsy Market, By Product Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 3.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Product Type, 2017, 2023, 2028
  • Table 4.1: Global Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 4.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Sample Type, 2017, 2023, 2028
  • Table 5.1: Global Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 5.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Biomarker Type, 2017, 2023, 2028
  • Table 6.1: Global Liquid Biopsy Market, By Cancer Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 6.8: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Cancer Type, 2017, 2023, 2028
  • Table 7.1: Global Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 7.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by End User, 2017, 2023, 2028
  • Table 8.1: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Leading Nationals, 2017, 2023, 2028
  • Table 8.2: Global Liquid Biopsy Market, By Leading Nationals, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.3: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.4: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
  • Table 8.5: US Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.6: Canada Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.7: Mexico Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.8: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.9: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
  • Table 8.10: Germany Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.11: France Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.12: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.13: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.14: Italy Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.15: Spain Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.16: Russia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.17: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.18: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
  • Table 8.19: Japan Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.20: China Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.21: Australia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.22: South Korea Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.23: India Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.24: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.25: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
  • Table 8.26: Brazil Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.27: Turkey Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.28: Venezuela Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.29: Saudi Arabia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 8.30: Republic of South Africa Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
  • Table 9.1: Silicon Biosystems Product Portfolio
  • Table 9.2: Silicon Biosystems Recent Developments
  • Table 9.3: MDxHealth SA Financials ($m), 2015-2017
  • Table 9.4: MDxHealth SA Product Portfolio
  • Table 9.5: MDxHealth SA Recent Developments
  • Table 9.6: Biocept Financials ($thousand), 2014-2016
  • Table 9.7: Biocept Product Portfolio
  • Table 9.8: Biocept Recent Developments
  • Table 9.9: Trovagene, Inc. Financials ($thousand), 2015-2017
  • Table 9.10: Trovagene, Inc. Product Portfolio
  • Table 9.11: Trovagene, Inc. Recent Developments
  • Table 9.12: Sysmex Inostics Product Portfolio
  • Table 9.13: Sysmex Inostics Financials ($m), 2015-2017
  • Table 9.14: Sysmex Inostics GmbH Recent Developments
  • Table 9.15: Roche Financials ($m), 2015-2017
  • Table 9.16: Roche Product Portfolio
  • Table 9.17: Roche Recent Developments
  • Table 9.18: Bio-Rad Financials ($m), 2014-2016
  • Table 9.19: Bio-Rad Product Portfolio
  • Table 9.20: Bio-Rad Recent Developments
  • Table 9.21: Guardant Product Portfolio
  • Table 9.22: Guardant Recent Developments
  • Table 9.23: Illumina Financials ($m), 2014-2016
  • Table 9.24: Illumina (GRAIL) Recent Developments
  • Table 9.25: Myriad Financials ($m), 2015-2017
  • Table 9.26: Myriad Product Portfolio
  • Table 9.27: Myriad Recent Developments
  • Table 9.28: Qiagen Financials ($m), 2015-2017
  • Table 9.29: Qiagen Product Portfolio
  • Table 9.30: Qiagen Recent Developments

Table of Figures

  • Figure 2.1 Ageing Population Estimates 2010 - 2050
  • Figure 2.2: Global Liquid Biopsy Market Revenue ($m), 2017-2028
  • Figure 3.1: Global Liquid Biopsy Market Revenue ($m), By Product Type, 2017-2028
  • Figure 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), 2017-2028
  • Figure 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), 2017-2028
  • Figure 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), 2017-2028
  • Figure 4.1: Global Liquid Biopsy Market Revenue ($m), By Sample Type, 2017-2028
  • Figure 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), 2017-2028
  • Figure 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), 2017-2028
  • Figure 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), 2017-2028
  • Figure 5.1: Global Liquid Biopsy Market Revenue ($m), By Biomarker Type, 2017-2028
  • Figure 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), 2017-2028
  • Figure 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), 2017-2028
  • Figure 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), 2017-2028
  • Figure 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), 2017-2028
  • Figure 6.1: Global Liquid Biopsy Market Revenue ($m), By Cancer Type, 2017-2028
  • Figure 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), 2017-2028
  • Figure 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), 2017-2028
  • Figure 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), 2017-2028
  • Figure 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), 2017-2028
  • Figure 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), 2017-2028
  • Figure 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), 2017-2028
  • Figure 7.1: Global Liquid Biopsy Market Revenue ($m), By End User, 2017-2028
  • Figure 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), 2017-2028
  • Figure 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), 2017-2028
  • Figure 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), 2017-2028
  • Figure 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), 2017-2028
  • Figure 8.1: Global Liquid Biopsy Market Revenue ($m), By Leading Nationals, 2017-2028
  • Figure 8.2: North America Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.3: US Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.4: Canada Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.5: Mexico Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.6: Europe Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.7: Germany Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.8: France Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.8: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.9: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.10: Italy Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.11: Spain Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.12: Russia Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.13: Asia-Pacific Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.14: Japan Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.15: China Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.16: Australia Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.17: South Korea Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.18: India Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.19: LAMEA Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.20: Brazil Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.21: Turkey Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.22: Venezuela Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.23: Saudi Arabia Liquid Biopsy Market, Revenue ($m), 2017-2028
  • Figure 8.24: Republic of South Africa Liquid Biopsy Market, Revenue ($m), 2017-2028

Companies Listed

  • Astellas
  • AstraZeneca
  • Bio Rad Laboratories Inc
  • Biocept Inc
  • Bristol Myers Squibb
  • Catalyst Pharmaceuticals
  • Cerba Healthcare
  • Clearbridge BioMedics (Singapore)
  • Clinical Genomics
  • Clovis Oncology
  • Daiichi Sankyo
  • Foundation Medicine, Inc.
  • G-TAC Co., Ltd. (Japan)
  • Guardant Health Inc
  • HarlePhil Ventures
  • HistoGeneX N.V
  • Illumina Inc
  • Inostics GmbH
  • Janssen
  • LabCorp (U.S.)
  • M3, Inc. (U.S.).
  • Maccura Biotechnology Co., Ltd.
  • MDxHealth SA
  • MedNcrease Health Plans LLC
  • Menarini Group
  • Merck KGaA
  • Merck Serono (Switzerland)
  • Miraca Life Sciences
  • Myriad Genetics
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NovioGendix Holding B.V
  • Novogene Co. Ltd
  • OncoMed Pharmaceuticals
  • Pathway Genomics Corporation
  • Pfizer
  • Qiagen N.V
  • Roche Holding AG
  • Silicon Biosystems
  • Silicon Biosystems S.p.A
  • SouthGenetics
  • Swift Biosciences
  • Sysmex Inostics GmbH
  • Teva Pharmaceuticals
  • Trovagene
  • Unilabs

Organisations Mentioned in This Report

  • Addario Lung Cancer Medical Institute
  • Centre for Medicare and Medicaid Services (CMS)
  • Dana-Farber Cancer Institute (U.S.)
  • European Databank on Medical Devices (EUDAMED)
  • Japanese Ministry of Health Labour and Welfare (MHLW)
  • Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
  • Ministry of Health (China)
  • National Cancer Center East Japan
  • National Health Laboratory of Myanmar
  • National Institute of Statistics and Economic Studies
  • OHSU Knight Cancer Institute
  • UK National Health Service (NHS)
  • United Nations (UN)
  • University of California (U.S.)
  • University of Michigan Comprehensive Cancer
  • University of Michigan Comprehensive Cancer Center
  • University of Southern California (U.S.)
  • University of Tokyo
  • US Food and Drug Administration (FDA)
  • US Oncology Research
  • USC Norris Comprehensive Cancer Center
  • World Health Organization (WHO)
Back to Top